Mark A. Glickman

Insider Reports History

Entity
Individual
Location
C/O Esperion Therapeutics, Inc., 3891 Ranchero Drive, Suite 150, Ann Arbor, MI
Signature
/s/ Phillip D. Torrence, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark A. Glickman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NeuroBo Pharmaceuticals, Inc. Director Common Stock 9.74K $30.5K $3.13 Jun 7, 2024 Direct
TherapeuticsMD, Inc. Co-Chief Executive Officer Restricted Stock Units 3.47K $12.6K $3.64 Dec 6, 2022 Direct
TherapeuticsMD, Inc. Co-Chief Executive Officer Common Stock 1.29K $2.9K $2.24 Dec 6, 2022 Direct

Insider Reports Filed by Mark A. Glickman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NRBO NeuroBo Pharmaceuticals, Inc. Jun 7, 2024 1 $0 4 Jun 7, 2024 Director
NRBO NeuroBo Pharmaceuticals, Inc. Jul 27, 2023 2 $0 4 Jul 28, 2023 Director
NRBO NeuroBo Pharmaceuticals, Inc. May 11, 2023 0 $0 3 May 12, 2023 Director
TXMD TherapeuticsMD, Inc. Dec 6, 2022 3 -$2.17K 4 Dec 9, 2022 Co-Chief Executive Officer
TXMD TherapeuticsMD, Inc. Mar 31, 2022 1 $0 4 Mar 31, 2022 Chief Business Officer
TXMD TherapeuticsMD, Inc. Mar 23, 2022 1 $0 4 Mar 28, 2022 Chief Business Officer
TXMD TherapeuticsMD, Inc. Oct 15, 2021 3 $0 4 Oct 15, 2021 Chief Business Officer
TXMD TherapeuticsMD, Inc. Oct 15, 2021 0 $0 3 Oct 15, 2021 Chief Business Officer